Shariat SF - Search Results

1

Assessment of Prostate and Bladder Cancer Genomic Biomarkers Using Artificial Intelligence: a Systematic Review.

Bazarkin A, Morozov A, Androsov A, Fajkovic H, Rivas JG, Singla N, Koroleva S, Teoh JY, Zvyagin AV, Shariat SF, Somani B, Enikeev D. Bazarkin A, et al. Among authors: shariat sf. Curr Urol Rep. 2024 Jan;25(1):19-35. doi: 10.1007/s11934-023-01193-2. Epub 2023 Dec 15. Curr Urol Rep. 2024. PMID: 38099997 Review.

2

Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy.

Singh H, Canto EI, Shariat SF, Kadmon D, Miles BJ, Wheeler TM, Slawin KM. Singh H, et al. Among authors: shariat sf. J Urol. 2004 Mar;171(3):1089-92. doi: 10.1097/01.ju.0000112763.74119.d4. J Urol. 2004. PMID: 14767277

3

Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.

Karam JA, Lotan Y, Ashfaq R, Sagalowsky AI, Shariat SF. Karam JA, et al. Among authors: shariat sf. Urology. 2007 Sep;70(3):482-6. doi: 10.1016/j.urology.2007.05.009. Urology. 2007. PMID: 17905101

4

Molecular markers in bladder cancer.

Shariat SF, Karam JA, Lerner SP. Shariat SF, et al. Curr Opin Urol. 2008 Jan;18(1):1-8. doi: 10.1097/MOU.0b013e3282f1c5c1. Curr Opin Urol. 2008. PMID: 18090481 Review.

5

Inventory of prostate cancer predictive tools.

Shariat SF, Karakiewicz PI, Margulis V, Kattan MW. Shariat SF, et al. Curr Opin Urol. 2008 May;18(3):279-96. doi: 10.1097/MOU.0b013e3282f9b3e5. Curr Opin Urol. 2008. PMID: 18382238 Review.

6

Combination of multiple molecular markers can improve prognostication in patients with locally advanced and lymph node positive bladder cancer.

Shariat SF, Chade DC, Karakiewicz PI, Ashfaq R, Isbarn H, Fradet Y, Bastian PJ, Nielsen ME, Capitanio U, Jeldres C, Montorsi F, Lerner SP, Sagalowsky AI, Cote RJ, Lotan Y. Shariat SF, et al. J Urol. 2010 Jan;183(1):68-75. doi: 10.1016/j.juro.2009.08.115. J Urol. 2010. PMID: 19913255

7

Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers.

Shariat SF, Youssef RF, Gupta A, Chade DC, Karakiewicz PI, Isbarn H, Jeldres C, Sagalowsky AI, Ashfaq R, Lotan Y. Shariat SF, et al. J Urol. 2010 May;183(5):1744-50. doi: 10.1016/j.juro.2010.01.018. Epub 2010 Mar 17. J Urol. 2010. PMID: 20299037

8

Prognostic effect of urinary bladder carcinoma in situ on clinical outcome of subsequent upper tract urothelial carcinoma.

Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Langner C, Montorsi F, Bolenz C, Margulis V. Youssef RF, et al. Among authors: shariat sf. Urology. 2011 Apr;77(4):861-6. doi: 10.1016/j.urology.2010.09.032. Epub 2010 Dec 16. Urology. 2011. PMID: 21167566

9

Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder.

Youssef RF, Shariat SF, Kapur P, Kabbani W, Mosbah A, Abol-Enein H, Ghoniem M, Lotan Y. Youssef RF, et al. Among authors: shariat sf. J Urol. 2011 Mar;185(3):1112-7. doi: 10.1016/j.juro.2010.10.036. Epub 2011 Jan 21. J Urol. 2011. PMID: 21255800

10

Impact of gender on bladder cancer incidence, staging, and prognosis.

Fajkovic H, Halpern JA, Cha EK, Bahadori A, Chromecki TF, Karakiewicz PI, Breinl E, Merseburger AS, Shariat SF. Fajkovic H, et al. Among authors: shariat sf. World J Urol. 2011 Aug;29(4):457-63. doi: 10.1007/s00345-011-0709-9. Epub 2011 Jun 9. World J Urol. 2011. PMID: 21656173 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,823 results

Search Page